These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 26005197)

  • 1. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.
    Ramji DP; Davies TS
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):673-85. PubMed ID: 26005197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages heterogeneity in atherosclerosis - implications for therapy.
    Wilson HM
    J Cell Mol Med; 2010 Aug; 14(8):2055-65. PubMed ID: 20629993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory reactions in the pathogenesis of atherosclerosis.
    Fan J; Watanabe T
    J Atheroscler Thromb; 2003; 10(2):63-71. PubMed ID: 12740479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of inflammation in atherogenesis].
    Rodríguez G; Mago N; Rosa F
    Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis.
    Buckley ML; Ramji DP
    Biochim Biophys Acta; 2015 Jul; 1852(7):1498-510. PubMed ID: 25887161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular extracellular matrix in atherosclerosis.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on lipids, inflammation and atherothrombosis.
    Badimon L; Storey RF; Vilahur G
    Thromb Haemost; 2011 May; 105 Suppl 1():S34-42. PubMed ID: 21479344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?
    Harvey EJ; Ramji DP
    Cardiovasc Res; 2005 Jul; 67(1):11-20. PubMed ID: 15907820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammatory process in atherogenesis: new facts about old flame].
    Vucević D; Radak D; Radosavljević T; Mladenović D; Milovanović I
    Med Pregl; 2012; 65(9-10):388-95. PubMed ID: 23214332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage: A Key Therapeutic Target in Atherosclerosis?
    Taghizadeh E; Taheri F; Renani PG; Reiner Ž; Navashenaq JG; Sahebkar A
    Curr Pharm Des; 2019; 25(29):3165-3174. PubMed ID: 31470780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological significance of cylindromatosis in the vascular endothelium and macrophages for the initiation of age-related atherogenesis.
    Imaizumi Y; Takami Y; Yamamoto K; Nagasawa M; Nozato Y; Nozato S; Takeshita H; Wang C; Yokoyama S; Hayashi H; Hongyo K; Akasaka H; Takeya Y; Sugimoto K; Nakagami H; Rakugi H
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1168-1174. PubMed ID: 30554661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
    Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
    J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.
    Hasegawa A; Sato K; Shirai R; Watanabe R; Yamamoto K; Watanabe K; Nohtomi K; Hirano T; Watanabe T
    PLoS One; 2014; 9(12):e110866. PubMed ID: 25462164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
    Tedgui A; Mallat Z
    Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular recruitment in myocardial ischaemia/reperfusion injury.
    Bonaventura A; Montecucco F; Dallegri F
    Eur J Clin Invest; 2016 Jun; 46(6):590-601. PubMed ID: 27090739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.